A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome

Abstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type...

Full description

Bibliographic Details
Main Authors: Jianzheng Fang, Gao Gao, Jinyong Liu, Lingbo Cai, Yugui Cui, Xiaoyu Yang
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.1801
_version_ 1830282001389715456
author Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
author_facet Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
author_sort Jianzheng Fang
collection DOAJ
description Abstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type 2 (AMHR2) genes. The main purpose of the study is to determine the novel mutations of AMHR2 in PMDS patients and their intracytoplasmic sperm injection outcomes (ICSI). Methods Whole‐exome sequencing (WES) was carried out. Sanger sequencing was used to detect mutations in AMHR2. The pathogenicity of the identified variant and its possible effects on the protein were evaluated with in silico tools. The expression level of AMHR2 was determined by Western blotting. The spermatogenic function was evaluated by testicular sperm aspiration and histopathologic examination. The ICSI outcomes were recorded. Results We present two brothers with a history of bilateral cryptorchidism with orchidopexy and infertility due to azoospermia. A novel compound heterozygous mutation of c.1219C>T [p.R407X] and c.1387C>T [p.R463C] in exons 9 and 10 of AMHR2 (NM_020547.2) was detected by whole‐exome sequencing (WES). Spermatozoon could be retrieved from the two patients by testicular aspiration following intracytoplasmic sperm injection (ICSI) due to azoospermia. Finally, patient 1 had two healthy boys and patient 2 failed to conceive after three ICSI attempts. Conclusion The spermatozoa could obtain from PMDS patients due to azoospermia. For patients with bilateral cryptorchidism, PMDS should be included in the differential diagnosis and that genetic counseling needs to be considered when they seek reproductive help.
first_indexed 2024-12-19T02:29:41Z
format Article
id doaj.art-62bdb091c8f64a2e938dd811d41609a5
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-12-19T02:29:41Z
publishDate 2021-10-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-62bdb091c8f64a2e938dd811d41609a52022-12-21T20:39:42ZengWileyMolecular Genetics & Genomic Medicine2324-92692021-10-01910n/an/a10.1002/mgg3.1801A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcomeJianzheng Fang0Gao Gao1Jinyong Liu2Lingbo Cai3Yugui Cui4Xiaoyu Yang5State Key Laboratory of Reproductive Medicine Clinical Center of Reproductive Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing ChinaThe Kangda College of Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Clinical Center of Reproductive Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Clinical Center of Reproductive Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Clinical Center of Reproductive Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing ChinaState Key Laboratory of Reproductive Medicine Clinical Center of Reproductive Medicine The First Affiliated Hospital of Nanjing Medical University Nanjing ChinaAbstract Background Persistent Müllerian duct syndrome (PMDS) is defined as the presence of Müllerian duct derivatives in an otherwise normally virilized 46, XY male. It is usually caused by homozygous or compound heterozygous mutations in either the anti‐Müllerian hormone (AMH) or AMH receptor type 2 (AMHR2) genes. The main purpose of the study is to determine the novel mutations of AMHR2 in PMDS patients and their intracytoplasmic sperm injection outcomes (ICSI). Methods Whole‐exome sequencing (WES) was carried out. Sanger sequencing was used to detect mutations in AMHR2. The pathogenicity of the identified variant and its possible effects on the protein were evaluated with in silico tools. The expression level of AMHR2 was determined by Western blotting. The spermatogenic function was evaluated by testicular sperm aspiration and histopathologic examination. The ICSI outcomes were recorded. Results We present two brothers with a history of bilateral cryptorchidism with orchidopexy and infertility due to azoospermia. A novel compound heterozygous mutation of c.1219C>T [p.R407X] and c.1387C>T [p.R463C] in exons 9 and 10 of AMHR2 (NM_020547.2) was detected by whole‐exome sequencing (WES). Spermatozoon could be retrieved from the two patients by testicular aspiration following intracytoplasmic sperm injection (ICSI) due to azoospermia. Finally, patient 1 had two healthy boys and patient 2 failed to conceive after three ICSI attempts. Conclusion The spermatozoa could obtain from PMDS patients due to azoospermia. For patients with bilateral cryptorchidism, PMDS should be included in the differential diagnosis and that genetic counseling needs to be considered when they seek reproductive help.https://doi.org/10.1002/mgg3.1801AMH receptor type 2cryptorchidismintracytoplasmic sperm injection (ICSI)mutationPersistent Müllerian duct syndrome
spellingShingle Jianzheng Fang
Gao Gao
Jinyong Liu
Lingbo Cai
Yugui Cui
Xiaoyu Yang
A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
Molecular Genetics & Genomic Medicine
AMH receptor type 2
cryptorchidism
intracytoplasmic sperm injection (ICSI)
mutation
Persistent Müllerian duct syndrome
title A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_full A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_fullStr A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_full_unstemmed A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_short A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
title_sort novel mutation of amhr2 in two brothers with persistent mullerian duct syndrome and their intracytoplasmic sperm injection outcome
topic AMH receptor type 2
cryptorchidism
intracytoplasmic sperm injection (ICSI)
mutation
Persistent Müllerian duct syndrome
url https://doi.org/10.1002/mgg3.1801
work_keys_str_mv AT jianzhengfang anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT gaogao anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jinyongliu anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT lingbocai anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT yuguicui anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT xiaoyuyang anovelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jianzhengfang novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT gaogao novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT jinyongliu novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT lingbocai novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT yuguicui novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome
AT xiaoyuyang novelmutationofamhr2intwobrotherswithpersistentmullerianductsyndromeandtheirintracytoplasmicsperminjectionoutcome